Formation of N-acyl-phosphatidylethanolamines and N-acylethanolamines -: Proposed role in neurotoxicity

被引:70
作者
Hansen, HS [1 ]
Lauritzen, L [1 ]
Moesgaard, B [1 ]
Strand, AM [1 ]
Hansen, HH [1 ]
机构
[1] Royal Danish Sch Pharm, Dept Sci Biol, DK-2100 Copenhagen, Denmark
关键词
N-acyl-phosphatidylethanolamine; N-acylethanolamine; anandamide; neurotoxicity; cannabinoid; 2-arachidonoylglycerol; brain ischemia; glutamate; neuroprotection;
D O I
10.1016/S0006-2952(97)00396-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The formation of N-acyl-phosphatidylethanolamine (NAPE) and N-acylethanolamine (NAE), including anandamide, in mammals in relation to neurotoxicity is discussed. Data on the characterization of the NAPE-forming N-acyltransferase, the NAPE-hydrolyzing phospholipase D, and the NAE-hydrolyzing amidase are reviewed. We suggest that NAPE and NAE, including anandamide, are formed in neurons in response to the high intracellular calcium concentrations that occur in injured neurons, e.g. due to glutamate excitotoxicity. NAPE may have functions of its own besides being a precursor for NAE. The formation of both of these lipids may serve as a cytoprotective response, whether mediated by physical interactions with membranes or enzymes, or mediated by activation of cannabinoid receptors. This suggestion implies that NAPE and NAE may have pathophysiological roles in the brain. Whether these lipids also have physiological roles is uncertain. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:719 / 725
页数:7
相关论文
共 97 条
[1]   BRADYKININ STIMULATES ARACHIDONIC-ACID RELEASE THROUGH THE SEQUENTIAL ACTIONS OF AN SN-1 DIACYLGLYCEROL LIPASE AND A MONOACYLGLYCEROL LIPASE [J].
ALLEN, AC ;
GAMMON, CM ;
OUSLEY, AH ;
MCCARTHY, KD ;
MORELL, P .
JOURNAL OF NEUROCHEMISTRY, 1992, 58 (03) :1130-1139
[2]   GLUTAMATE-INDUCED NEURONAL DEATH - A SUCCESSION OF NECROSIS OR APOPTOSIS DEPENDING ON MITOCHONDRIAL-FUNCTION [J].
ANKARCRONA, M ;
DYPBUKT, JM ;
BONFOCO, E ;
ZHIVOTOVSKY, B ;
ORRENIUS, S ;
LIPTON, SA ;
NICOTERA, P .
NEURON, 1995, 15 (04) :961-973
[3]   Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides [J].
Barg, J ;
Fride, E ;
Hanus, L ;
Levy, R ;
MatusLeibovitch, N ;
Heldman, E ;
Bayewitch, M ;
Mechoulam, R ;
Vogel, Z .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 287 (02) :145-152
[4]   Inhibition of anandamide hydrolysis in rat brain tissue by (E)-6-(bromomethylene) tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one [J].
Beltramo, M ;
diTomaso, E ;
Piomelli, D .
FEBS LETTERS, 1997, 403 (03) :263-267
[5]   Anandamide - A new look on fatty acid ethanolamides [J].
Berdyshev, EV ;
Boichot, E ;
Lagente, V .
JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1996, 15 (01) :49-67
[6]   Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes [J].
Bisogno, T ;
Maurelli, S ;
Melck, D ;
DePetrocellis, L ;
DiMarzo, V .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (06) :3315-3323
[7]   Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells [J].
Bisogno, T ;
Sepe, N ;
Melck, D ;
Maurelli, S ;
DePetrocellis, L ;
DiMarzo, V .
BIOCHEMICAL JOURNAL, 1997, 322 :671-677
[8]   PHYSIOLOGICAL-EFFECTS OF INVERSE AGONISTS IN TRANSGENIC MICE WITH MYOCARDIAL OVEREXPRESSION OF THE BETA(2)-ADRENOCEPTOR [J].
BOND, RA ;
LEFF, P ;
JOHNSON, TD ;
MILANO, CA ;
ROCKMAN, HA ;
MCMINN, TR ;
APPARSUNDARAM, S ;
HYEK, MF ;
KENAKIN, TP ;
ALLEN, LF ;
LEFKOWITZ, RJ .
NATURE, 1995, 374 (6519) :272-276
[9]  
Bonner TI, 1996, J NEUROIMMUNOL, V69, P15
[10]  
Cadas H, 1996, J NEUROSCI, V16, P3934